New Generation Artificial Tears: The Solution for DED

Dear Dr. Renukaprasad A R, Are artificial tears safe and effective in managing dry eye diseases (DED)? DED is a growing ocular health complication. However, it can be managed with next-generation artificial tears, which create a viscous-elastic matrix on the ocular surface, providing enough lubrication for a long time. Additionally, next-generation artificial tears do not pose any safety concerns and are poised to be the first-line therapy for DED. Learn more about the clinical benefits of artificial tears for DED management through this infographic! Key highlights: Components of artificial tears Beneficial effects of newer artificial tears Clinical utility of artificial tear components Click to Read Docplexus is one of the world's largest online communities Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

HOPE & HF Care: Why Does It Matter?

Dear Dr. Renukaprasad A R, Do you support the use of empagliflozin for heart failure patients, irrespective of their diabetic status? Recent studies demonstrate that empagliflozin reduces the risk of hospitalization and death among heart failure patients. However, the proper use of drugs is essential for better treatment outcomes. Check out this booklet, "HOPE", with seven chapters covering the basic aspects of empagliflozin along with its utility in various fields ranging from endocrinology to cardiology and nephrology. Highlights: Common ground for cardiovascular, kidney, and metabolic effects Three levels of disease modification with SGLT2-i SGLT2-i as evolving Standards of CARE (CVD, adiposity, renal disease, endocrinology) The interlinking of mechanisms and possible risks CVD:  Cardiovascular disease; SGLT2-i: Sodium-glucose cotransport-2 inhibitor Read More Docplexus is one of the world's largest online communities Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Xerosis in Diabetes – How Do You Manage It?

� � �Docplexus is one of the world's largest online communities Hello Renukaprasad A R, Many diabetic patients are prone to cutaneous complications, ranging from esthetic to life-threatening. Xerosis is one of the most common manifestations of diabetes-related cutaneous complications, affecting about 40% of patients. Take this 2-minute survey to help us understand your views on diabetes-related xerosis and its management. Share Your Views Do you often check blood sugar levels in patients with xerosis? Yes, for all patient populations Yes, but only for geriatric patients Depending on the patient's history Pune - 411025, INDIA info@docplexus.co.in | +91-98500 36954 � Copyright 2022 Docplexus.com Manage Preferences | Unsubscribe

Anti-retroviral Drugs Can Reduce Mother-to-Child Transmission of HIV, and More

Hi Renukaprasad A R, Top Stories of the Day: Anti-retroviral Drugs Can Reduce Mother-to-Child Transmission of HIV WHO to Draft a Legally Binding Pandemic Accord Regulator Nod for Shingles Vaccine in India Antibodies to Antibiotics Can Lead to T1DM Risk Webinar: Head and Neck Reconstruction Healthcare headlines that matter, brought to you every day by Docplexus Health Minute! Watch News Docplexus is one of the world's largest online communities Pune - 411045, India Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Ticagrelor in the Medical Management of ACS Patients

Dear Dr. Renukaprasad A R, Nearly half of all deaths worldwide are caused by cardiovascular diseases, with ischemic heart disease and acute coronary syndrome accounting for most deaths. Dual antiplatelet therapy (DAPT) is a crucial part of the recovery process for those with the acute coronary syndrome and has proven successful in secondary prevention in ACS patients. Ticagrelor, an efficient antiplatelet drug, demonstrates higher efficacy in lowering the rate of cardiovascular adverse events. Check out this article summarizing different clinical trials investigating the efficacy of ticagrelor and highlighting their outcomes in terms of safety, efficacy, and mortality profile. Click to Read Docplexus is one of the world's largest online communities Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Single Lubricant for All DED Subtypes

Dear Dr. Renukaprasad A R, A single treatment for the multifaceted dry eye disease (DED) condition is a novel therapy! The prevalence of DED varies by country, ranging from 5% to 34%. DED directly affects the interpalpebral ocular surface and tear film, thus resulting in vision disruption. A single solution for the multifactorial disease is the need of the hour, especially for treating advanced DED. Propylene glycol (PG) and hydroxypropyl guar (HPG) with nano-sized lipid excipients optimize the lipid surface and maintain a healthy ocular surface. Additionally, it offers the surface epithelium a shield of defense. Watch this video to learn how this formulation applies to all DED subtypes! Highlights: DED classification PG-HPG formulation and mode of action Impact of PG-HPG formulation on the ocular surface Watch the Video Docplexus is one of the world's largest online communities Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*